After 26 weeks, researchers found that all dose concentrations of elecoglipron reduced glucose levels significantly more than placebo
doi: 10.3389/fmolb.2023.1210347 Received 22 April 2023 Accepted 06 September 2023 Published 15 September 2023 Volume 10 - 2023 Edited by Venkateswarlu Kanamarlapudi, Swansea University Medical School, United Kingdom Reviewed by Syed Muhammad Usama, University of Texas at San Antonio, United States Gregg Stanwood, Florida State University, United States Ming Yang, University of California, San Diego, United States Updates Copyright 2023 Xie, Wang, Pei and Chen
Regulators warn about serious side effects as well as common reactions such as nausea and flushing
New interpretation of oral glucose tolerance
We know that patients taking GLP-1 RAs have an increased incidence of residual gastric contents even when fasting